Depressive disorder is one of the most widespread forms of psychiatric pathology,
worldwide. According to a report by the World Health Organization, the number of people …

Depression is a significant public health problem but symptom remission is difficult to
predict. This may be due to substantial heterogeneity underlying the disorder. Latent class …

It is well known that depressive disorder is heterogeneous, yet little is known about its
neurophysiological subtypes. In the present study, we identified neurophysiological …

Background: Depressive disorder is one of the main health problems worldwide. Many risk
factors have been associated with this pathology. However, while the association between …

Objective Depression has been associated with increased mortality rates, and modifying
mechanisms have not yet been elucidated. We examined whether specific subtypes or …

Background Owing to high heterogeneity and comorbidity, the shared and unique neural
mechanisms underlying the development of anxiety and major depressive disorders remain …

Drug development for mood disorders can greatly benefit from the development of robust,
reliable, and objective biomarkers. The incorporation of smartphones and wearable devices …

Background: Depression is a common and potentially life-threatening mental illness, and
currently, there is a lack of effective treatment. It has been reported that dehydrocorydaline …

BackgroundEtiological research of depression and anxiety disorders has been hampered by
diagnostic heterogeneity. In order to address this, researchers have tried to identify more …

Depression is one of the most prevalent psychiatric mood diseases worldwide, whose
therapy is in urgent need of development. Although the neuroprotective effects of …